Synthetic Marijuana Now is Medicine but Cannabis is Still Illegal
The DEA has announced that the company Insys has produced a synthetic marijuana product and the DEA deems it medically valuable and safer than real cannabis. The announcement was made on November 22nd in the Federal Register by the DEA. The drug is called Syndros. It’s a liquid form of synthetic THC that will be classified as a schedule 2 controlled substance. At this level, the drug can be prescribed by doctors legally, at the federal level.
On March 23, 2017, the DEA published an interim final rule to make FDA-approved products containing dronabinol in an oral solution a schedule II controlled substance. 82 FR 14815. The interim final rule provided an opportunity for interested persons to file written comments as well as a request for hearing or waiver of hearing, on or before April 24, 2017.”
Meanwhile, marijuana will continue to be listed as a “Schedule 1 controlled substance”. Schedule 1 is reserved for drugs like heroin, deemed to have “no currently accepted medical use” and have “a high potential for abuse.” As Politico says, “Jeff Sessions Isn’t Giving up on Weed. He’s Doubling Down.”
The FDA has cleared Syndros for Synthetic Marijuana Approval
Synthetic marijuana will be hitting the market soon. Insys Therapeutics is based out of Arizona. This is not the kind of company marijuana advocates want involved in the cannabis industry.
A pharmaceutical company that manufactures the prescription painkiller fentanyl repeatedly misrepresented its product and the patients using it in order to boost sales, according to a blistering report released Wednesday by Sen. Claire McCaskill (D-Mo.).” – Mother Jones
We found a story on Collective Evolution:
Twenty-nine states and Washington, D.C. have now legalized some form of medical marijuana; however the DEA and the FDA still maintain their stance that cannabis is not medicine. Last year, the FDA even rejected a petition to have marijuana removed from the Schedule 1 category.”